Genetic association of Ctla-4 to myasthenia gravis with thymoma

Journal of Neuroimmunology

Volumn 88, Issue 1-2, 1998, Pages 192-198

  Huang, DeRen ^a   Liu, Li ^b   Norén, Kristina ^a   Xia, ShiQin ^b   Trifunovic, Jasmina ^a   Pirskanen, Ritva ^a   Lefvert, Ann Kari ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Co stimulation; CTLA 4; Disease heterogeneity; Myasthenia gravis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THYMOMA;

ADULT; ALLELES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOIMMUNE DISEASES; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; GENE FREQUENCY; GENETIC MARKERS; HUMANS; IMMUNOCONJUGATES; MALE; MYASTHENIA GRAVIS; POLYMORPHISM, GENETIC; REFERENCE VALUES; THYMOMA; THYMUS NEOPLASMS;

EID: 0032146465     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00119-2     Document Type: Article

References (34)

1. Aarli, J.A., Stefansson, K., Marton, L.S.G., Wollmann, R.L., 1990. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin. Exp. Immunol. 82, 284-288.
2. Aarli, J.A., Gilhus, N.B., Matre, R., 1992. Myasthenia gravis with thymoma is not associated with an increased incidence of non-muscle autoimmune disorders. Autoimmunity 11, 159-162.
3. Åhlberg, R., Yi, Q., Pirskanen, R., Matell, G., Swerup, C., Rieber, E.P., Riethmuller, G., Holm, G., Lefvert, A.K., 1994. Treatment of myasthenia gravis with anti-CD4 antibody: Improvement correlates to decreased T cell autoreactivity. Neurology 44, 1732-1737.
4. Brunei, J.F., Denizot, F., Luciani, M.F., Roux-Dosseto, M., Suzan, M., Mattei, M.G., Golstein, P., 1987. A new member of the immunoglobulin superfamily-CTLA-4. Nature 328, 267-328.
5. Carlsson, B., Wallin, J., Pirskanen, R., Matell, G., Smith, C.I.E., 1990. Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis. Immunogenetics 31, 285-290.
6. Cibotti, R., Punt, J.A., Dash, K.S., Sharrow, S.O., Singer, A., 1997. Surface molecules that drive T cell development in vitro in the absence of thymic epithelium and in the absence of lineage-specific signals. Immunity 6, 245-255.
7. Danling, G., Wogensen, L., Calcutt, N.A., Chunyao, X., Powell, H.C., Sarvetnick, N., 1995. Myasthenia gravis-like syndrome induced by expression of interferon γ in the neuromuscular junction. J. Exp. Med. 181, 547-557.
8. + thymocytes. J. Immunol. 152, 3254-3263.
9. Drachman, D.B., 1994. Myasthenia gravis. New Eng. J. Med. 330, 1797-1810.
10. Garchon, H.J., Djabiri, F., Viard, J.P., Gajdos, P., Bach, J.F., 1994. Involvement of human muscle acetylcholine receptor α-subunit gene (CHRNA) in susceptibility to myasthenia gravis. Proc. Natl. Acad. Sci. U.S.A. 91, 4668-4672.
11. Guerder, S., Picarella, D.E., Linsley, P.S., Flavell, R.A., 1994. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor a leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 91, 5138-5142.
12. Harper, K., Balzano, C., Rouvier, E., Mattéi, M.G., Luciani, M.F., Golstein, P., 1991. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147, 1037-1044.
13. Hjelmström, P., Peacock, C.S., Giscombe, R., Pirskanen, R., Lefvert, A.K., Blackwell, J.M., Sanjeevi, C.B., 1998. Polymorphism in the tumor necrosis factor-α and interleukin-1 gene regions are associated with myasthenia gravis. J. Neuroimmunol. 88, 137-143.
14. Huang, D.R., Pirskanen, R., Hjelmström, P., Lefvert, A.K., 1997. Polymorphisms in IL-1β and IL-1 receptor antagonist genes are associated with myasthenia gravis. J. Neuroimmunol. 81, 76-81.
15. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155, 1032-1036.
16. Krummel, M.F., Allison, J.P., 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533-2540.
17. Lafage, M., Maroc, N., Dubreuil, P., Waal Malefijt, R., Pébusque, M.J., Carcassonne, Y., Mannoni, P., 1989. The human interleukin-1α gene is located on the long arm of chromosome 2 at band q13. Blood 73, 104-107.
18. Leach, D.R., Krummel, M.F., Allison, J.P., 1996. Enhancement of antitumor immunity by CTLA-4: blockade. Science 271, 1734-1736.
19. Lefvert, A.K., Bergström, K., Matell, G., Osterman, P.O., Pirskanen, R., 1978. Determination of acetylcholine receptor antibodies in myasthenia gravis. J. Neurol. Neurosurg. Psychiat. 41, 394-403.
20. Levisetti, M.G., Padrid, P.A., Szot, G.L., Mittaal, N., Meehan, S.M., Wardrip, C.L., Gray, G.S., Bruce, D.S., Thistlethwaite, J.R. Jr., Bluestone, J.A., 1997. Immunosuppressive effects of human CTLA-4 IG in a non-human primate model of allogeneic pancreatic islet transplantation. J. Immunol. 159, 5187-5191.
21. Liu, Y., 1997. Is CTLA-4 a negative regulator for T cell activation?. Immunol. Today 18, 569-572.
22. Maselli, R.A., Richman, D.P., Wollman, R.L., 1991. Inflammation at the neuromuscular junction in myasthenia gravis. Neurology 41, 1497-1504.
23. Moulian, N., Bidault, J., Truffault, F., Yamamoto, A.M., Levasseur, P., Berrih-Aknin, S., 1997. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody. Blood 89, 3287-3295.
24. Belgian Diabetes Registry, Nisticò, L., Buzzetti, R., Pritchard, L.E., Van der Auwera, B., Giovannini, C., Bosi, E., Larrad, M.T.M., Rios, M.S., Chow, C.C., Cockram, C.S., Jacobs, K., Mijovic, C., Bain, S.C., Barnett, A.M., Vandewalle, C.L., Schuit, F., Gorus, F.K., Tosi, R., Pozzilli, P., Todd, J.A., 1996. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, Type 1 diabetes. Hum. Mol. Gen. 5, 1075-1080.
25. Rulifson, I.C., Sperling, A.I., Fields, P.E., Fitch, F.W., Bluestone, J.A., 1997. CD28 co-stimulation promotes the production of Th2 cytokines. J. Immunol. 158, 658-665.
26. Shaw, G., Kamen, R., 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-667.
27. Silver, A.R.J., Masson, W.K., George, A.M., Adam, J., Cox, R., 1990. The IL-1α and β genes are closely linked ( < 70 kb) on mouse chromosome 2. Somatic Cell. Mol. Genet. 16, 549-556.
28. Spurkland, A., Gilhus, N.B., Ronningen, K.S., Aarli, J.A., Vartdal, F., 1991. Myasthenia gravis patients with thymus hyperplasai and myasthenia gravis patients with thymoma display different HLA associations. Tissue Antigens 37, 90-93.
29. Tivol, E.A., Bordello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A., Sharpe, A.H., 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
30. Tivol, E.A., Boyd, S.D., Mc Keon, S., Borriello, F., Nickerson, P., Strom, T.B., Sharoe, A.H., 1997. CTLA-4 Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 158, 5091-5094.
31. Truffault, F., Cohen-Kaminsky, S., Khalil, I., Levasseur, P., Berrih-Aknin, S., 1997. Altered intrathymic T cell repertoire in human myasthenia gravis. Ann. Neurol. 41, 731-741.
32. Wagner, D.H. Jr., Hagman, J., Linsley, P.S., Hodsdon, W., Freed, J.H., Newell, M.K., 1996. Rescue of Thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2. J. Exp. Med. 184, 1631-1638.
33. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shahinian, A., Lee, K.P., Thompson, C.B., Griesser, H., Mak, T.W., 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988.
34. Yanagawa, T., Hidaka, Y., Guimaraes, V., Soliman, M., De Groot, L.J., 1995. CTLA-4 gene polymorphism associated with Grave's disease in a caucasian population. J. Clin. Endocrinol. 80, 41-45.